title: Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.
authors.forename: Georg
authors.initials: G
authors.lastname: Hess
authors.forename: Volker
authors.initials: V
authors.lastname: Wagner
authors.forename: Andreas
authors.initials: A
authors.lastname: Kreft
authors.forename: Claus Peter
authors.initials: CP
authors.lastname: Heussel
authors.forename: Christoph
authors.initials: C
authors.lastname: Huber
mesh_terms: D001803:Blood Transfusion; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005871:Castleman Disease / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D015850:Interleukin-6; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib